ARGENX SE revenue for the last year amounted to 21.55 B MXN, the most of which — 20.83 B MXN — came from its highest performing source at the moment, Antibody-based Medicines, the year earlier bringing 8.01 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought ARGENX SE 18.29 B MXN, and the year before that — 7.37 B MXN.